EWTX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2022-08-04 compared with 2022-05-11 · 1 added, 3 removed, 39 unchanged (9% of the section changed)
4 unchanged sentences
Exhibit Description
−Removed: Sales Agreement, dated April 1, 2022, by and between Edgewise Therapeutics, Inc.
−Removed: and Cowen and Company, LLC.
−Removed: April 1, 2022
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
24 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized.
+Added: August 4, 2022
EDGEWISE THERAPEUTICS, INC.
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.